rare cancer

September 7, 2021 · Richard L. Schilsky, MD, FACP, FSCT, FASCO
Algunas aprobaciones recientes de la Administración de Alimentos y Medicamentos (Food and Drug Administration, FDA) han hecho que las personas se enteren de que hay tratamientos agnósticos con respecto a los tumores. Pero, ¿qué significa eso y cómo podría beneficiar a alguien con cáncer? El director médico anterior (2013-2021) de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica), Richard L. Schilsky, aporta información sobre esta nueva forma de abordar el tratamiento del cáncer. Read More >>
Your Stories: Conquering Cancer
September 8, 2020 · Jimmy O’Hara, Conquer Cancer staff
In this “Your Stories” podcast from Conquer Cancer, the ASCO Foundation, Dr. Mark Lewis discusses with Dr. Jonathan Bleeker how having a patient’s perspective changed how he cares for people with cancer. Read More >>
Your Stories: Conquering Cancer
April 22, 2020 · Jimmy O’Hara, Conquer Cancer staff
In this “Your Stories” podcast from Conquer Cancer, the ASCO Foundation, Dr. Nizar Tannir and Dr. Pavlos Msaouel discuss filling the need for research on rare cancers. Read More >>
December 20, 2018 · Richard L. Schilsky, MD, FACP, FSCT, FASCO
Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment. Read More >>